Friedrich Maritsch

448 total citations
9 papers, 339 citations indexed

About

Friedrich Maritsch is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Friedrich Maritsch has authored 9 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 3 papers in Epidemiology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Friedrich Maritsch's work include SARS-CoV-2 and COVID-19 Research (3 papers), Influenza Virus Research Studies (3 papers) and Vector-borne infectious diseases (3 papers). Friedrich Maritsch is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), Influenza Virus Research Studies (3 papers) and Vector-borne infectious diseases (3 papers). Friedrich Maritsch collaborates with scholars based in Austria, United States and Singapore. Friedrich Maritsch's co-authors include Borislava G. Pavlova, Perry Barrett, Hartmut J. Ehrlich, Werner Engl, H. P. Schwarz, Gerald Eder, Fred S. Rosen, Sandor Fritsch, Alexandra Loew-Baselli and Alexandra Löw‐Baselli and has published in prestigious journals such as The Journal of Infectious Diseases, Vaccine and Transfusion.

In The Last Decade

Friedrich Maritsch

9 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Friedrich Maritsch Austria 8 148 109 103 97 95 9 339
Kathleen A. Rogers United States 10 154 1.0× 10 0.1× 158 1.5× 193 2.0× 111 1.2× 11 371
Claire Bories France 7 89 0.6× 24 0.2× 21 0.2× 147 1.5× 60 0.6× 20 319
Carlos Eugênio Cavasini Brazil 16 75 0.5× 51 0.5× 447 4.3× 202 2.1× 76 0.8× 24 600
P. Hall United Kingdom 8 57 0.4× 12 0.1× 288 2.8× 120 1.2× 72 0.8× 10 452
Maxmillian Mpina Tanzania 12 118 0.8× 12 0.1× 160 1.6× 36 0.4× 59 0.6× 24 401
Shikha Shrivastava India 9 62 0.4× 9 0.1× 197 1.9× 45 0.5× 256 2.7× 26 462
Banson Barugahare Uganda 7 97 0.7× 9 0.1× 27 0.3× 49 0.5× 98 1.0× 14 518
Martin Zydek United States 14 209 1.4× 10 0.1× 30 0.3× 34 0.4× 312 3.3× 20 524
P. D. Smith United States 10 109 0.7× 9 0.1× 13 0.1× 88 0.9× 98 1.0× 11 354
Johnson Aj United States 9 70 0.5× 15 0.1× 15 0.1× 135 1.4× 29 0.3× 21 303

Countries citing papers authored by Friedrich Maritsch

Since Specialization
Citations

This map shows the geographic impact of Friedrich Maritsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Friedrich Maritsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Friedrich Maritsch more than expected).

Fields of papers citing papers by Friedrich Maritsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Friedrich Maritsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Friedrich Maritsch. The network helps show where Friedrich Maritsch may publish in the future.

Co-authorship network of co-authors of Friedrich Maritsch

This figure shows the co-authorship network connecting the top 25 collaborators of Friedrich Maritsch. A scholar is included among the top collaborators of Friedrich Maritsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Friedrich Maritsch. Friedrich Maritsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Maritsch, Friedrich, et al.. (2022). Data privacy protection in scientific publications: process implementation at a pharmaceutical company. BMC Medical Ethics. 23(1). 65–65. 7 indexed citations
2.
Ehrlich, Hartmut J., Markus Müller, Herwig Kollaritsch, et al.. (2012). Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine. Vaccine. 30(30). 4543–4551. 14 indexed citations
3.
Tambyah, Paul Anantharajah, Annelies Wilder‐Smith, Borislava G. Pavlova, et al.. (2011). Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine. Vaccine. 30(2). 329–335. 22 indexed citations
4.
Bauer, Martin, Sandor Fritsch, Borislava G. Pavlova, et al.. (2010). Clinical evaluation to determine the appropriate paediatric formulation of a tick-borne encephalitis vaccine. Vaccine. 28(29). 4558–4565. 16 indexed citations
5.
Bauer, Martin, Borislava G. Pavlova, Alexandra Löw‐Baselli, et al.. (2010). Comparison of immunogenicity and safety between two paediatric TBE vaccines. Vaccine. 28(29). 4680–4685. 25 indexed citations
6.
Ehrlich, Hartmut J., Markus Müller, Sandor Fritsch, et al.. (2009). A Cell Culture (Vero)–Derived H5N1 Whole‐Virus Vaccine Induces Cross‐Reactive Memory Responses. The Journal of Infectious Diseases. 200(7). 1113–1118. 44 indexed citations
7.
Loew-Baselli, Alexandra, Ryszard Konior, Borislava G. Pavlova, et al.. (2006). Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN®: Results of two large phase 3 clinical studies. Vaccine. 24(24). 5256–5263. 51 indexed citations
8.
Ehrlich, Hartmut J., Borislava G. Pavlova, Sandor Fritsch, et al.. (2003). Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity. Vaccine. 22(2). 217–223. 46 indexed citations
9.
Engl, Werner, et al.. (1998). A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema. Transfusion. 38(6). 540–549. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathleen A. Rogers Breakdown of academic impact, for papers by Claire Bories Breakdown of academic impact, for papers by Carlos Eugênio Cavasini Breakdown of academic impact, for papers by P. Hall Breakdown of academic impact, for papers by Maxmillian Mpina Breakdown of academic impact, for papers by Shikha Shrivastava Breakdown of academic impact, for papers by Banson Barugahare Breakdown of academic impact, for papers by Martin Zydek Breakdown of academic impact, for papers by P. D. Smith Breakdown of academic impact, for papers by Johnson Aj
Rankless by CCL
2026